Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Rheinische Friederich-Wilhelms-Universitaet Bonn discloses MRGPRX4 agonists

May 11, 2022

Sunshine Lake Pharma patents new GNRHR antagonists

April 22, 2022

Soltego discloses new SIK inhibitors

April 8, 2022

Can-Fite developing topical formulation of piclidenoson for the treatment of psoriasis

April 6, 2022

Novel TLR4 murine model to study dermal sensitization by nickel salts

April 4, 2022

PF-07038124: a topical PDE4 inhibitor for atopic dermatitis and plaque psoriasis

March 29, 2022

Seoul National University Hospital patents triglyceride-lowering peptides

March 29, 2022

Dompe Farmaceutici describes new peptides with angiogenic activity

March 28, 2022

Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides

March 17, 2022

VYN-201 reduces key inflammatory biomarkers involved in vitiligo pathogenesis in preclinical model

March 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...